(Q44585478)

English

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions

scientific article published on 15 September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Paul A Voziyan

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Raja G Khalifah

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Christophe Thibaudeau

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Alaattin Yildiz

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jaison Jacob

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Anthony S Serianni

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Billy G Hudson

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

15 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

278

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

46616-46624

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Role of the Maillard reaction in diabetes mellitus and diseases of aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Molecular basis for a link between complement and the vascular complications of diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Advanced glycation end products in children with chronic renal failure and type 1 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Age-related accumulation of Maillard reaction products in human articular cartilage collagen

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Chelating activity of advanced glycation end-product inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Nonenzymatic Glucosylation of Serum Proteins in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M307155200

21 January 2018

Identifiers

10.1074/JBC.M307155200

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44585478&oldid=2028666670"